Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Arch Gen Psychiatry. 2010 Mar;67(3):277–285. doi: 10.1001/archgenpsychiatry.2009.204

Table 1.

Demographics, including Z scores

Total (N=217) Dropouts (N=27) Completers (N=190) p-value
White race, n (%) (n=217) 198 (91.2%) 25 (92.6%) 173 (91.1%) 1.00
Sex, male, n (%) (n=217) 96 (44.2%) 13 (48.2%) 83 (43.7%) 0.68
Late age of onset (≥ age 60), n (%) (n=199) 90 (45.2%) 7 (38.9%) 83 (45.9%) 0.63
Age, mean (SD) (n=217) 68.4 (7.2) 67.8 (6.3) 68.6 (7.3) 0.79
Age of onset, mean (SD) (n=199) 53.6 (17.2) 53.4 (15.7) 53.6 (17.3) 0.86
Education, mean (SD) (n=217) 14.2 (3.1) 13.2 (3.1) 14.4 (3.1) 0.09
MMSE, mean (SD) (n=216) 27.7 (2.0) 27.4 (2.3) 27.8 (2.0) 0.43
VRF, mean (SD) (n=211) 11.7 (4.6) 11.6 (4.6) 11.7 (4.6) 0.96
Baseline MADRS, mean (SD) (n=217) 26.0 (4.4) 25.1 (4.5) 26.1 (4.4) 0.25
Episodic Memory, mean (SD) (n=198) -0.34 (3.1) -0.03 (2.8) -0.37 (3.2) 0.66
Language Processing, mean (SD) (n=193) -0.10 (2.3) 0.12 (2.2) -0.12 (2.4) 0.45
Working Memory, mean (SD) (n=197) -0.04 (2.3) -0.74 (2.1) 0.03 (2.3) 0.10
Processing Speed, mean (SD) (n=192) 0.004 (2.5) 0.54 (2.3) -0.05 (2.6) 0.31
Executive Function, mean (SD) (n=184) -0.10 (3.3) 0.12 (3.2) -0.12 (3.4) 0.80
Total Fazekas Score, mean (SD) (n=184) 4.2 (2.4) 4.5 (2.5) 4.2 (2.3) 0.56
Total Fazekas Categorical (Fazekas Total>2), n (%) (n=184) 127 (69.0%) 8 (80.0%) 119 (68.4%) 0.73
Last Sertraline Dose (mg), mean (SD) (n=204) 114.0 (54.2) 72.2 (38.2) 118.0 (53.9) 0.0007

Note: Fisher's exact test for categorical variables and Wilcoxon Rank-Sum test for continuous variables